| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 50.50B | 60.76B | 59.60B | 60.07B | 52.44B |
| Gross Profit | 23.71B | 27.37B | 25.18B | 24.17B | 22.18B |
| EBITDA | 11.11B | 11.74B | 11.99B | 13.07B | 10.82B |
| Net Income | 5.99B | 5.74B | 6.49B | 7.64B | 6.05B |
Balance Sheet | |||||
| Total Assets | 70.56B | 79.75B | 75.27B | 77.82B | 75.09B |
| Cash, Cash Equivalents and Short-Term Investments | 5.07B | 7.63B | 6.11B | 5.52B | 4.50B |
| Total Debt | 29.64B | 30.66B | 28.59B | 28.44B | 29.67B |
| Total Liabilities | 52.95B | 57.20B | 54.50B | 56.12B | 55.35B |
| Stockholders Equity | 15.55B | 19.99B | 18.10B | 19.02B | 17.11B |
Cash Flow | |||||
| Free Cash Flow | 6.39B | 7.55B | 7.68B | 5.66B | 6.73B |
| Operating Cash Flow | 7.78B | 9.52B | 9.43B | 7.28B | 7.97B |
| Investing Cash Flow | -3.65B | -625.00M | -2.29B | 2.45B | -3.25B |
| Financing Cash Flow | -5.69B | -6.94B | -7.19B | -8.89B | -7.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.71B | 8.95 | 9.27% | 1.62% | 0.50% | 20.52% | |
71 Outperform | £96.30B | 11.79 | 26.01% | 3.85% | -16.19% | 8.30% | |
69 Neutral | £12.86B | 7.89 | 8.44% | 2.98% | -2.16% | -24.87% | |
66 Neutral | £32.93B | 4.45 | 21.39% | 5.00% | -4.98% | -35.54% | |
66 Neutral | £30.20B | 4.35 | 38.45% | 3.44% | 0.25% | 131.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | £322.17M | 14.34 | -2.16% | 4.82% | 6.74% | 26.11% |